Exact Sciences Corporation
EXAS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $850,739 | $811,085 | $706,785 | $713,424 |
| % Growth | 4.9% | 14.8% | -0.9% | – |
| Cost of Goods Sold | $266,810 | $248,632 | $206,238 | $284,200 |
| Gross Profit | $583,929 | $562,453 | $500,547 | $429,224 |
| % Margin | 68.6% | 69.3% | 70.8% | 60.2% |
| R&D Expenses | $117,290 | $108,901 | $105,310 | $99,617 |
| G&A Expenses | $241,413 | $208,582 | $220,686 | $342,400 |
| SG&A Expenses | $491,641 | $455,700 | $484,996 | $433,600 |
| Sales & Mktg Exp. | $250,228 | $247,118 | $264,310 | $91,200 |
| Other Operating Expenses | $543 | $0 | $6,251 | $772,358 |
| Operating Expenses | $609,474 | $564,601 | $596,557 | $1,305,575 |
| Operating Income | -$25,545 | -$2,148 | -$96,010 | -$876,351 |
| % Margin | -3% | -0.3% | -13.6% | -122.8% |
| Other Income/Exp. Net | $7,788 | $2,091 | -$4,981 | $385 |
| Pre-Tax Income | -$17,757 | -$57 | -$100,991 | -$875,966 |
| Tax Expense | $1,837 | $1,128 | $224 | -$11,381 |
| Net Income | -$19,594 | -$1,185 | -$101,215 | -$864,585 |
| % Margin | -2.3% | -0.1% | -14.3% | -121.2% |
| EPS | -0.1 | -0.006 | -0.54 | -4.67 |
| % Growth | -1,487.3% | 98.8% | 88.4% | – |
| EPS Diluted | -0.1 | -0.006 | -0.54 | -4.67 |
| Weighted Avg Shares Out | 189,263 | 188,902 | 186,813 | 185,312 |
| Weighted Avg Shares Out Dil | 189,262 | 188,902 | 186,813 | 185,312 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $9,789 | $9,835 | $8,819 | $8,246 |
| Depreciation & Amortization | $55,882 | $55,283 | $54,061 | $53,147 |
| EBITDA | $47,914 | $53,135 | -$38,111 | -$814,573 |
| % Margin | 5.6% | 6.6% | -5.4% | -114.2% |